Synonyms: Hengqu® | SHR-8735
hetrombopag is an approved drug (China (2021))
Compound class:
Synthetic organic
Comment: Hetrombopag is an orally bioavailable, non-peptide small‐molecule thrombopoietin receptor (TPOR/MPL) agonist, that was developed as a treatment for thrombocytopenia [1]. The parent compound is shown here. It is administered as the ethanolamine/olamine.
|
|
Download 2D Structure | |
Canonical SMILES | Download |
Isomeric SMILES | Download |
InChI standard identifier | Download |
InChI standard key | Download |
Molecular structure representations generated using Open Babel